BioCorRx, Inc. Enters Agreement with BioWyze, LLC
August 27, 2014 08:00 ET
|
BioCorRx
Los Angeles, Aug. 27, 2014 (GLOBE NEWSWIRE) -- BioCorRx, Inc. (BICX),
developer of the Start Fresh Program™, announces the
execution of an agreement with BioWyze, LLC. BioWyze...
BioCorRx, Inc. Completes License Agreement for Distribution of its Start Fresh Program in Nevada
July 17, 2014 08:00 ET
|
BioCorRx
Los Angeles, July 17, 2014 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB:
BICX), a leader in addiction treatment and rehabilitation programs,
announced it has closed a sale for the exclusive license...
BioCorRx, Inc. Announces Distribution Rights in Ohio for Start Fresh Program
July 01, 2014 08:00 ET
|
BioCorRx
Los Angeles, July 1, 2014 (GLOBE NEWSWIRE) -- BioCorRx, Inc. (OTCQB:
BICX), a leader in addiction treatment and rehabilitation programs,
announced it has closed another sale for the exclusive...
BioCorRx, Inc. Completes Licensing Agreement for Rights to Washington, D.C., Maryland, Virginia, West Virginia, and North Carolina
May 19, 2014 11:30 ET
|
BioCorRx
Los Angeles, May 19, 2014 (GLOBE NEWSWIRE) -- BioCorRx, Inc.
(OTCQB: BICX), a leader in alcohol treatment and rehabilitation
programs, announces the completion of the exclusive license...
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology
April 22, 2014 07:41 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., April 22, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today the issuance of U.S. Patent No. 8,703,186 titled...
Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study for Abuse Deterrent Product ELI-200
March 05, 2014 07:30 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., March 5, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today successful results from a pivotal bioequivalence study initiated...
BioCorRx Inc. Announces Expansion of the Start Fresh Program to Include Treatment of Opioid Dependence
March 04, 2014 07:00 ET
|
BioCorRx
Los Angeles, March 4, 2014 (GLOBE NEWSWIRE) -- BioCorRx Inc. ('the Company")
(OTCQB: BICX) is pleased to announce the expansion of their
revolutionary Start Fresh Program. In light of an...
Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201
February 18, 2014 07:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 18, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") ("Elite") (OTCBB:ELTP) announced today successful results from a pilot bioequivalence study...
Elite Pharmaceuticals, Inc. Appoints Nasrat Hakim as President and Chief Executive Officer
August 05, 2013 07:00 ET
|
Elite Pharmaceuticals, Inc.
Elite Adds Twelve Approved Products to Its Pipeline
Conference Call Scheduled for 1 PM Eastern Time
NORTHVALE, N.J., Aug. 5, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP)...
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2013, FQ4/13 Revenues Highest in Corporate History
June 21, 2013 13:44 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., June 21, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral abuse-resistant...